BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August

Day

• 1
• 2
• 3
• 4
• 5
• 7
• 8
• 9
• 10
• 11
• 12
• 14
• 15
• 16
• 17
• 18
• 19
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30

• Press Releases

  AbCellera Appoints Dr. Victor Sandor to its Board of Directors

  June 7, 2026

   · 

  2 min read
• Press Releases

  Memo Therapeutics AG Presents Further Analyses of the Phase II Trial Results of Potravitug for the Treatment of BKPyV Infection in Kidney Transplant Recipients in an Oral Presentation at the 63rd European Renal Association Congress

  June 7, 2026

   · 

  4 min read
• Press Releases

  Nyxoah Announces Pricing of $95 Million Underwritten Public Offering

  June 7, 2026

   · 

  12 min read
• Press Releases

  IntraBio Announces Submission of Variation Application to the European Medicines Agency for AQNEURSA® for Ataxia-Telangiectasia

  June 7, 2026

   · 

  4 min read
• Press Releases

  Teva Presents New Data on AUSTEDO® (deutetrabenazine) tablets and AUSTEDO XR® (deutetrabenazine) extended-release tablets that Show Patient- and Caregiver-Reported Improvements in Huntington’s Disease Chorea

  June 7, 2026

   · 

  12 min read
• Press Releases

  Feinstein Institutes’ John M. Kane honored with 2026 Schizophrenia International Research Society Lifetime Achievement Award

  June 7, 2026

   · 

  3 min read
• Press Releases

  Vertex Presents New Data on ALYFTREK® at European Cystic Fibrosis Conference

  June 7, 2026

   · 

  17 min read
• Press Releases

  Altesa BioSciences Presents New Phase 2 Vapendavir Challenge Study Results at 2026 American Society for Microbiology (ASM) Microbe Conference

  June 7, 2026

   · 

  3 min read
• 

  Weight loss

  ADA: Lilly’s weight loss mastery shows benefits in menopause, sleep apnea, more

  Eli Lilly sauntered into the American Diabetes Association meeting with a commanding lead in the metabolic space and put down more evidence for its pipeline, including new pill Foundayo and next-gen asset retatrutide, in new indications.

  June 7, 2026

   · 

  2 min read

   · 

  Annalee Armstrong
• Press Releases

  SynbioTech Launches SYNMUE™ Targeting Immunosenescence, to Showcase at Probiota Americas 2026 in Vancouver

  June 7, 2026

   · 

  7 min read